MDI-P has demonstrated potent anti-HIV activity. MDI-P has been shown to be effective in killing HIV in cell culture. HIV is the virus that causes acquired immune deficiency syndrome (AIDS).... MDI-P is also a potential therapeutic agent for the treatment of the symptoms of cystic fibrosis ("CF").
- Mechanism
- Curator reviewed
MDI-P's mechanism of action is not accomplished by enzyme or nucleic acid inhibition, but rather by direct intra-cellular effects. MDI-P is very rapid in effect and destroys viruses without destroying host cells.
- Primary indication
- Investigated for use/treatment in asthma, cystic fibrosis, and HIV infection.Curator reviewed
- Formula / weight
- C13H19NO2 · 221.3 g/mol (avg)
- Also known as
- MDI-P · MDIP · MDIPA
Resolves to
XKEVWMVUIDDRMC-UHFFFAOYSA-NSMILESCC(C)NC(C)CC1=CC2=C(OCO2)C=C1What you can answer from here — as of April 02, 2025
Which companies are running trials of 3,4-Methylenedioxy-N-isopropylamphetamine, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account